Gemphire Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GEMP and buy or sell other stocks, ETFs, and their options commission-free!About GEMP
Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand.
CEOSteve Gullans, PhD
CEOSteve Gullans, PhD
Employees9
Employees9
HeadquartersLivonia, Michigan
HeadquartersLivonia, Michigan
Founded2014
Founded2014
Employees9
Employees9
GEMP Key Statistics
Market cap25.10M
Market cap25.10M
Price-Earnings ratio-0.19
Price-Earnings ratio-0.19
Dividend yield—
Dividend yield—
Average volume73.85K
Average volume73.85K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.16
52 Week high$5.16
52 Week low$0.63
52 Week low$0.63